Akorn, Inc. Announces Positive Phase III Pivotal Trial Results for Akten(R)
2007年1月23日 - 9:00PM
ビジãƒã‚¹ãƒ¯ã‚¤ãƒ¤ï¼ˆè‹±èªžï¼‰
Akorn, Inc. (AMEX: AKN) today announced the positive results of a
Phase III pivotal trial for Akten�. The clinical trial was a
randomized, placebo controlled, multi-centered, 4-arm trial in 209
subjects. The primary efficacy end point for achieving ocular
anesthesia (p
Safety First Trust Principal-Protected Trust Certificates Linked TO A U.S.-Europe-Japan Basket Structured Product (AMEX:AKN)
éŽåŽ» æ ªä¾¡ãƒãƒ£ãƒ¼ãƒˆ
ã‹ã‚‰ 6 2024 ã¾ã§ 7 2024
Safety First Trust Principal-Protected Trust Certificates Linked TO A U.S.-Europe-Japan Basket Structured Product (AMEX:AKN)
éŽåŽ» æ ªä¾¡ãƒãƒ£ãƒ¼ãƒˆ
ã‹ã‚‰ 7 2023 ã¾ã§ 7 2024
Real-Time news about Safety First Trust Principal-Protected Trust Certificates Linked TO A U.S.-Europe-Japan Basket Structured Product (アメリカ証券å–引所): 0 recent articles
ãã®ä»–ã®Akorn, Inc.ニュース記事